{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:54:48Z","timestamp":1792695288154,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.kint.2024.07.036","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T07:15:40Z","timestamp":1726643740000},"page":"1062-1071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clonal monocytosis of renal significance"],"prefix":"10.1016","volume":"106","author":[{"given":"Anuya A.","family":"Natu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5651-1411","authenticated-orcid":false,"given":"Nelson","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9072-9871","authenticated-orcid":false,"given":"Mariam P.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal M.","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2024.07.036_bib1","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1038\/s41467-021-23186-w","article-title":"RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis","volume":"12","author":"Carr","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2024.07.036_bib2","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41467-022-29142-6","article-title":"Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia","volume":"13","author":"Binder","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2024.07.036_bib3","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/ng.3400","article-title":"The genomic landscape of juvenile myelomonocytic leukemia","volume":"47","author":"Stieglitz","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2024.07.036_bib4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2018-11-844688","article-title":"Juvenile myelomonocytic leukemia: who\u2019s the driver at the wheel?","volume":"133","author":"Niemeyer","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.kint.2024.07.036_bib5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.kint.2024.07.036_bib6","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1182\/blood-2009-07-234666","article-title":"Chronic myeloid leukemia with p190BCR-ABL: prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis","volume":"114","author":"Pardanani","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.kint.2024.07.036_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11899-021-00660-2","article-title":"Myeloproliferative neoplasms with monocytosis","volume":"17","author":"Morsia","year":"2022","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.kint.2024.07.036_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11899-021-00618-4","article-title":"Differential diagnosis and workup of monocytosis: a systematic approach to a common hematologic finding","volume":"16","author":"Mangaonkar","year":"2021","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.kint.2024.07.036_bib9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood-2019-01-896084","article-title":"Clonal monocytosis of clinical significance","volume":"133","author":"Cazzola","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.kint.2024.07.036_bib10","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.3390\/cancers15123175","article-title":"Myelodysplastic syndromes\/myeloproliferative overlap neoplasms and differential diagnosis in the WHO and ICC 2022 Era: a focused review","volume":"15","author":"Fontana","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.kint.2024.07.036_bib11","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.3390\/cancers15153815","article-title":"Definitions, Biology, and current therapeutic landscape of myelodysplastic\/myeloproliferative neoplasms","volume":"15","author":"Gerke","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.kint.2024.07.036_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106640","article-title":"Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy","volume":"109","author":"Hunter","year":"2021","journal-title":"Leuk Res"},{"key":"10.1016\/j.kint.2024.07.036_bib13","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.ekir.2023.05.007","article-title":"Clinicopathologic Spectrum of Lysozyme-Associated Nephropathy","volume":"8","author":"Kudose","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2024.07.036_bib14","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood-2018-08-867333","article-title":"The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis","volume":"133","author":"Cargo","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.kint.2024.07.036_bib15","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ajh.27271","article-title":"Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management","volume":"99","author":"Patnaik","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.kint.2024.07.036_bib16","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1182\/bloodadvances.2019000585","article-title":"The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations","volume":"3","author":"Franzini","year":"2019","journal-title":"Blood. Adv"},{"key":"10.1016\/j.kint.2024.07.036_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00918813","article-title":"Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe","volume":"16","author":"Bajaj","year":"1992","journal-title":"Inflammation"},{"key":"10.1016\/j.kint.2024.07.036_bib18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.124.5.921","article-title":"Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia","volume":"124","author":"Osserman","year":"1966","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2024.07.036_bib19","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1172\/JCI106387","article-title":"Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia","volume":"49","author":"Pruzanski","year":"1970","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2024.07.036_bib20","doi-asserted-by":"crossref","first-page":"E148","DOI":"10.1002\/ajh.26902","article-title":"Spectrum of renal pathological findings in patients with chronic myelomonocytic leukemia and kidney injury","volume":"98","author":"Gipe","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.kint.2024.07.036_bib21","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1016\/j.ekir.2023.09.005","article-title":"Chronic myelomonocytic leukemia patients with lysozyme nephropathy and renal infiltration display markers of severe disease","volume":"8","author":"Lafargue","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2024.07.036_bib22","first-page":"116","article-title":"Studies on hypermuramidasemia in the normal and chloroleukemic rat: the role of the kidney","volume":"81","author":"Greenberger","year":"1973","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.kint.2024.07.036_bib23","first-page":"47","article-title":"The relationship of lysozyme to the nephropathy in chloroleukemic rats and the effects of lysozyme loading on normal rat kidneys","volume":"34","author":"Klockars","year":"1974","journal-title":"Cancer Res"},{"key":"10.1016\/j.kint.2024.07.036_bib24","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/ccr3.2188","article-title":"Lysozyme nephropathy in chronic myelomonocytic leukemia","volume":"7","author":"Patel","year":"2019","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.kint.2024.07.036_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0002-9343(69)90219-8","article-title":"Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia","volume":"47","author":"Muggia","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.kint.2024.07.036_bib26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0272-6386(12)70154-3","article-title":"Renal failure and severe hypokalemia associated with acute myelomonocytic leukemia","volume":"22","author":"Perazella","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.07.036_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7326\/0003-4819-82-1-54","article-title":"Hypokalaemia in acute myeloid leukaemia","volume":"82","author":"Mir","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.kint.2024.07.036_bib28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-87-5-635_2","article-title":"Cellular proliferation and hypokalemia","volume":"87","author":"Schiffman","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.kint.2024.07.036_bib29","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/bmj.282.6269.1034","article-title":"Exaggerated hypokalaemia in acute myeloid leukaemia","volume":"282","author":"Adams","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.kint.2024.07.036_bib30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0002-9343(69)90036-9","article-title":"Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies","volume":"46","author":"Wiernik","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.kint.2024.07.036_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/243331a0","article-title":"Effects of lysozyme on normal and transformed mammalian cells","volume":"243","author":"Osserman","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.kint.2024.07.036_bib32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ekir.2020.12.005","article-title":"Kidney involvement in patients with chronic myelomonocytic leukemia or BCR-ABL\u2013negative myeloproliferative neoplasms","volume":"6","author":"Belliere","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2024.07.036_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000225262","article-title":"An autopsy study of the metastatic patterns of human leukemias","volume":"35","author":"Viadana","year":"1978","journal-title":"Oncology"},{"key":"10.1016\/j.kint.2024.07.036_bib34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.5858\/2001-125-0657-CMLRBU","article-title":"Chronic myelomonocytic leukemia revealed by uncontrollable hematuria","volume":"125","author":"Bane","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.kint.2024.07.036_bib35","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1080\/10428194.2018.1452212","article-title":"Nonhepatosplenic extramedullary manifestations of chronic myelomonocytic leukemia: clinical, molecular and prognostic correlates","volume":"59","author":"Hoversten","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.kint.2024.07.036_bib36","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ajh.23548","article-title":"What is a promonocyte?","volume":"88","author":"Bain","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.kint.2024.07.036_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s13730-020-00567-6","article-title":"A\u00a0rare cause of acute kidney injury with chronic myelomonocytic leukemia","volume":"10","author":"Asano","year":"2021","journal-title":"CEN Case Rep"},{"key":"10.1016\/j.kint.2024.07.036_bib38","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/modpathol.2015.117","article-title":"Renal extramedullary hematopoiesis: interstitial and glomerular pathology","volume":"28","author":"Alexander","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.kint.2024.07.036_bib39","first-page":"33","article-title":"Renal involvement by chronic myelomonocytic leukemia requiring nephroureterectomy","volume":"11","author":"Hyams","year":"2009","journal-title":"Rev Urol"},{"key":"10.1016\/j.kint.2024.07.036_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.leukres.2011.05.003","article-title":"Cutaneous manifestations in CMML: indication of disease acceleration or transformation to AML and review of the literature","volume":"36","author":"Mathew","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.kint.2024.07.036_bib41","article-title":"Extramedullary hematopoiesis in a sentinel lymph node as an early sign of chronic myelomonocytic leukemia","volume":"2015","author":"Bowen","year":"2015","journal-title":"Case Rep Pathol"},{"key":"10.1016\/j.kint.2024.07.036_bib42","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/jcp.46.7.674","article-title":"Pericardial extramedullary haemopoiesis in chronic myelomonocytic leukaemia","volume":"46","author":"Bradford","year":"1993","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.kint.2024.07.036_bib43","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/his.14282","article-title":"Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome\/myeloproliferative neoplasms","volume":"78","author":"B\u00fcttner-Herold","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.kint.2024.07.036_bib44","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.2011.147","article-title":"Myeloproliferative neoplasms cause glomerulopathy","volume":"80","author":"Said","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.07.036_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000365877","article-title":"A\u00a0close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution","volume":"133","author":"Peker","year":"2015","journal-title":"Acta Haematol"},{"key":"10.1016\/j.kint.2024.07.036_bib46","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1080\/10428194.2016.1243681","article-title":"Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia","volume":"58","author":"Zahid","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.kint.2024.07.036_bib47","first-page":"609","article-title":"Severe renal complications in chronic myelomonocytic leukemia","volume":"21","author":"Enriquez","year":"2008","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2024.07.036_bib48","first-page":"1303","article-title":"Acute kidney injury in a man with chronic myelomonocytic leukemia","volume":"35","author":"Sun","year":"2022","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2024.07.036_bib49","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00428-021-03129-y","article-title":"Renal post-mortem findings in myeloproliferative and myelodysplastic\/myeloproliferative neoplasms","volume":"479","author":"Person","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.kint.2024.07.036_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/08880019409141909","article-title":"Resolution of nephrocalcinosis associated with tumor lysis syndrome","volume":"11","author":"Wechsler","year":"1994","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.kint.2024.07.036_bib51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.ajkd.2008.11.013","article-title":"A\u00a0forgotten cause of kidney injury in chronic myelomonocytic leukemia","volume":"54","author":"Patel","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.07.036_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10354-022-00977-4","article-title":"Significance of reduced renal function in patients with chronic myelomonocytic leukemia","volume":"173","author":"Heschl","year":"2023","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.kint.2024.07.036_bib53","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3904\/kjim.2016.263","article-title":"Chronic kidney disease in the BCR-ABL1-negative myeloproliferative neoplasm: a single-center retrospective study","volume":"33","author":"Baek","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.kint.2024.07.036_bib54","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1182\/blood.V57.1.182.182","article-title":"5-Azacytidine and renal tubular dysfunction","volume":"57","author":"Peterson","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.kint.2024.07.036_bib55","unstructured":"VIDAZA(R), subcutaneous injection, intravenous injection, azacitidine subcutaneous injection, intravenous injection. Product information. Celgene Corporation. Drugs@FDA: FDA-Approved Drugs. Accessed October 14, 2024. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm"},{"key":"10.1016\/j.kint.2024.07.036_bib56","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1470-2045(19)30145-7","article-title":"Dose recommendations for anticancer drugs in patients with renal or hepatic impairment","volume":"20","author":"Krens","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.kint.2024.07.036_bib57","unstructured":"DACOGEN(R) intravenous injection, decitabine intravenous injection. Product information. Otsuka America Pharmaceutical Inc. (per FDA); 2018. Accessed October 14, 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/pediatric\/021790_decitabine_clinical_bpca.pdf"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824006367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824006367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T20:56:28Z","timestamp":1735332988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253824006367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0085253824006367"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2024.07.036","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal monocytosis of renal significance","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}